Brief: Moleculin Provides Update On Ongoing Clinical Trials And Outlines Expected Upcoming Milestones

Moleculin Biotech

10/08/2023 21:16

Aug 10 (Reuters) - Moleculin Biotech Inc  MBRX.O :
    * MOLECULIN PROVIDES UPDATE ON ONGOING CLINICAL TRIALS AND
OUTLINES EXPECTED UPCOMING MILESTONES
    * MOLECULIN BIOTECH: SUCCESSFUL COMPLETION OF PHASE 1B
PORTION OF
ITS PHASE 1B/2 CLINICAL TRIAL ANNAMYCIN IN COMBINATION WITH
CYTARABINE
    * MOLECULIN BIOTECH: ANNOUNCES A PRELIMINARY CR/CRI RATE OF
33%
(N=6) IN PHASE 1B PORTION OF ITS MB-106 CLINICAL TRIAL
    * MOLECULIN BIOTECH INC: MULTIPLE EXPECTED MILESTONES AND
INTERIM
DATA READOUTS EXPECTED IN 2023

Source text for Eikon:  ID:nPnc8DmTta 
Further company coverage:  MBRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))